Sandoz invites young entrepreneurs to enter #SandozHACk, a global competition to help solve healthcare access challenges
- Details
- Category: Novartis
Sandoz, the Novartis generic and biosimilar pharmaceutical division, announces the launch of Sandoz HACk - Healthcare Access Challenge - a global competition to generate innovative ideas and solutions to help tackle some of the world's most pressing healthcare access problems. The competition is open for entries until November 30, 2016.
Bristol-Myers Squibb and Nektar Therapeutics announce oncology clinical collaboration to evaluate the combination of Opdivo (nivolumab) and NKTR-214
- Details
- Category: Bristol-Myers Squibb
Bristol-Myers Squibb Company (NYSE:BMY) and Nektar Therapeutics (Nasdaq:NKTR) today announced a new clinical collaboration to evaluate Bristol-Myers Squibb's Opdivo (nivolumab) with Nektar's investigational medicine, NKTR-214, as a potential combination treatment regimen in five tumor types and seven potential indications.
Pfizer decides remaining one company best positions company to maximize future value creation
- Details
- Category: Pfizer
Pfizer Inc. (NYSE:PFE) announced that, after an extensive evaluation, the company's Board of Directors and Executive Leadership Team have determined the company is best positioned to maximize future shareholder value creation in its current structure and will not pursue splitting Pfizer Innovative Health and Pfizer Essential Health into two, separate publicly traded companies at this time.
Novel Novartis malaria compound shows potential to be effective against infections resistant to all currently available antimalarial drugs
- Details
- Category: Novartis
Novartis has published proof of concept study results in the New England Journal of Medicine showing that its new antimalarial compound, KAF156, demonstrated activity against both vivax and falciparum malaria, including artemisinin-resistant parasites.
Bristol-Myers Squibb awards first "Golden Tickets" for LabCentral to PanTher, Suono Bio
- Details
- Category: Bristol-Myers Squibb
Bristol-Myers Squibb Company (NYSE:BMY) and LabCentral, an innovative, shared laboratory space designed as a launch pad for life-sciences and biotech startups, today announced that PanTher and Suono Bio are the winners of Bristol-Myers Squibb's Golden Tickets for LabCentral. As a platinum sponsor of LabCentral, Bristol-Myers Squibb can select up to two innovative life-sciences and biotech startup companies per year of active sponsorship for "Golden Tickets," which underwrite the cost of one lab bench for one year in LabCentral's Kendall Square facility.
Abbott to sell Abbott Medical Optics to Johnson & Johnson for $4.325 billion
- Details
- Category: Abbott
Abbott (NYSE: ABT) announced today that it will sell Abbott Medical Optics, its vision care business, to Johnson & Johnson for $4.325 billion in cash. Abbott's vision business has products in areas including cataract surgery, laser vision correction (LASIK) and corneal care products (contact solution, eye drops, etc.).
Novartis Foundation showcases progress in leprosy elimination programs at 19th International Leprosy Congress
- Details
- Category: Novartis
The Novartis Foundation and its partners will highlight progress in efforts toward accelerating the elimination of leprosy at the 19th International Leprosy Congress (ILC) held in Beijing, China from September 18 - 21, 2016. Updates in 11 abstracts on four Novartis Foundation-supported leprosy initiatives in low- and middle-income countries will be showcased in scientific sessions.
More Pharma News ...
- Pfizer launches new "Moodivator" app to help support, encourage and motivate people with depression
- PEPFAR and AstraZeneca launch partnership across HIV and hypertension services in Africa
- Sanofi and Verily Life Sciences announce launch of Onduo, a joint venture to develop comprehensive diabetes management platform
- Roche ranked most sustainable healthcare company in the Dow Jones Sustainability Index for the eighth year running
- Pfizer appoints chief scientific officer for neuroscience research
- Bristol-Myers Squibb employees cycle Coast to Coast to raise money and awareness for cancer research
- GSK announce positive results from the COPD Salford Lung Study